Raymond Dwek, Director at UNITED THERAPEUTICS Corp (UTHR), sold 3,000 shares at $159.05 ($479K) on 2015-05-01, disclosed to the SEC on 2015-05-01.
Scheduled sale ($479k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $155.22 | 134 | $21K | 4.3% |
| 2 | $157.20 | 253 | $40K | 8.3% |
| 3 | $159.05 | 113 | $18K | 3.8% |
| 4 | $159.76 | 1,700 | $272K | 56.7% |
| 5 | $160.76 | 800 | $129K | 26.9% |
| Total | $159.58 avg | 3,000 |
| $479K |
| 100% |
| Filing → |
| UTHR | SELL | 2025-04-08 | $1.1M | — | Filing → |
| UTHR | SELL | 2024-08-05 | $1.6M | — | Filing → |
| UTHR | SELL | 2022-07-11 | $1.0M | — | Filing → |